DOLPHIN MEDI | DR. LAL PATHLABS | DOLPHIN MEDI/ DR. LAL PATHLABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -47.1 | 60.3 | - | View Chart |
P/BV | x | 0.3 | 12.5 | 2.5% | View Chart |
Dividend Yield | % | 0.0 | 0.5 | - |
DOLPHIN MEDI DR. LAL PATHLABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
DOLPHIN MEDI Mar-23 |
DR. LAL PATHLABS Mar-23 |
DOLPHIN MEDI/ DR. LAL PATHLABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 2 | 2,870 | 0.1% | |
Low | Rs | 2 | 1,763 | 0.1% | |
Sales per share (Unadj.) | Rs | 0.4 | 241.9 | 0.2% | |
Earnings per share (Unadj.) | Rs | -0.1 | 28.9 | -0.3% | |
Cash flow per share (Unadj.) | Rs | 0 | 46.9 | -0.1% | |
Dividends per share (Unadj.) | Rs | 0 | 12.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.5 | 0.0% | |
Book value per share (Unadj.) | Rs | 6.7 | 192.9 | 3.5% | |
Shares outstanding (eoy) | m | 15.10 | 83.37 | 18.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.5 | 9.6 | 47.2% | |
Avg P/E ratio | x | -22.2 | 80.1 | -27.7% | |
P/CF ratio (eoy) | x | -44.7 | 49.4 | -90.7% | |
Price / Book Value ratio | x | 0.3 | 12.0 | 2.3% | |
Dividend payout | % | 0 | 41.5 | -0.0% | |
Avg Mkt Cap | Rs m | 28 | 193,109 | 0.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 3,765 | 0.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6 | 20,169 | 0.0% | |
Other income | Rs m | 0 | 417 | 0.1% | |
Total revenues | Rs m | 6 | 20,586 | 0.0% | |
Gross profit | Rs m | -1 | 4,898 | -0.0% | |
Depreciation | Rs m | 1 | 1,502 | 0.0% | |
Interest | Rs m | 0 | 375 | 0.0% | |
Profit before tax | Rs m | -1 | 3,438 | -0.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 1,028 | 0.0% | |
Profit after tax | Rs m | -1 | 2,411 | -0.1% | |
Gross profit margin | % | -13.3 | 24.3 | -54.7% | |
Effective tax rate | % | -5.9 | 29.9 | -19.8% | |
Net profit margin | % | -20.4 | 12.0 | -170.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 20 | 9,731 | 0.2% | |
Current liabilities | Rs m | 7 | 4,698 | 0.1% | |
Net working cap to sales | % | 213.9 | 25.0 | 857.1% | |
Current ratio | x | 3.0 | 2.1 | 144.2% | |
Inventory Days | Days | 1,937 | 38 | 5,049.6% | |
Debtors Days | Days | 0 | 13 | 0.0% | |
Net fixed assets | Rs m | 102 | 13,721 | 0.7% | |
Share capital | Rs m | 151 | 834 | 18.1% | |
"Free" reserves | Rs m | -49 | 15,247 | -0.3% | |
Net worth | Rs m | 102 | 16,080 | 0.6% | |
Long term debt | Rs m | 8 | 833 | 0.9% | |
Total assets | Rs m | 122 | 23,451 | 0.5% | |
Interest coverage | x | -10.7 | 10.2 | -105.3% | |
Debt to equity ratio | x | 0.1 | 0.1 | 143.2% | |
Sales to assets ratio | x | 0.1 | 0.9 | 5.8% | |
Return on assets | % | -0.9 | 11.9 | -7.9% | |
Return on equity | % | -1.2 | 15.0 | -8.2% | |
Return on capital | % | -1.0 | 22.5 | -4.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0.5 | 0.0% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | 101 | 0.0% | |
Fx inflow | Rs m | 0 | 220 | 0.0% | |
Fx outflow | Rs m | 0 | 101 | 0.0% | |
Net fx | Rs m | 0 | 119 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1 | 4,560 | -0.0% | |
From Investments | Rs m | NA | -2,873 | -0.0% | |
From Financial Activity | Rs m | 1 | -2,832 | -0.0% | |
Net Cashflow | Rs m | 0 | -1,145 | -0.0% |
Indian Promoters | % | 26.4 | 52.6 | 50.3% | |
Foreign collaborators | % | 0.0 | 2.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 35.8 | - | |
FIIs | % | 0.0 | 26.2 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 73.6 | 45.4 | 162.0% | |
Shareholders | 9,349 | 146,741 | 6.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare DOLPHIN MEDI With: APOLLO HOSPITALS METROPOLIS HEALTHCARE NARAYANA HRUDAYALAYA KIMS VIJAYA DIAGNOSTIC
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | DOLPHIN MEDI | DR. LAL PATHLABS |
---|---|---|
1-Day | -4.57% | 0.84% |
1-Month | -17.72% | 5.24% |
1-Year | 26.67% | 23.05% |
3-Year CAGR | -4.77% | -6.27% |
5-Year CAGR | 9.46% | 18.29% |
* Compound Annual Growth Rate
Here are more details on the DOLPHIN MEDI share price and the DR. LAL PATHLABS share price.
Moving on to shareholding structures...
The promoters of DOLPHIN MEDI hold a 26.4% stake in the company. In case of DR. LAL PATHLABS the stake stands at 54.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of DOLPHIN MEDI and the shareholding pattern of DR. LAL PATHLABS.
Finally, a word on dividends...
In the most recent financial year, DOLPHIN MEDI paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
DR. LAL PATHLABS paid Rs 12.0, and its dividend payout ratio stood at 41.5%.
You may visit here to review the dividend history of DOLPHIN MEDI, and the dividend history of DR. LAL PATHLABS.
Indian share markets reversed the trend as the session progressed and ended the lower. After starting higher on Friday, equity markets had an anti-climatic end today.